Perrigo Gets "Wake-Up Call" In FDA Warning Letter

Perrigo prioritized correcting manufacturing problems that drew an FDA warning, advising the firm to prevent human errors with tighter quality control, according to CEO Joseph Papa

More from Archive

More from Pink Sheet